Market Closed -
Other stock markets
|
After market 11:56:44 am | |||
2.19 EUR | -0.68% | 2.195 | +0.23% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
Sales 2024 * | 46.78M 49.99M | Sales 2025 * | 74.41M 79.51M | Capitalization | 178M 190M |
---|---|---|---|---|---|
Net income 2024 * | -25M -26.71M | Net income 2025 * | -21M -22.44M | EV / Sales 2024 * | 2.41 x |
Net cash position 2024 * | 65.68M 70.18M | Net cash position 2025 * | 122M 130M | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
-15.2
x | P/E ratio 2025 * |
3.64
x | Employees | 179 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.91% |
Latest transcript on Innate Pharma
1 day | -0.23% | ||
1 week | -2.65% | ||
Current month | +0.69% | ||
1 month | -1.35% | ||
3 months | -13.73% | ||
6 months | -4.97% | ||
Current year | -16.03% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Vivier
FOU | Founder | 60 | 99-09-22 |
Chief Executive Officer | 62 | 99-09-22 | |
Frederic Lombard
DFI | Director of Finance/CFO | 49 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 99-09-22 | |
Gilles Brisson
BRD | Director/Board Member | 72 | 07-06-25 |
Olivier Martinez
BRD | Director/Board Member | 54 | 10-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 2.19 | -0.68% | 41 340 |
24-04-30 | 2.205 | -1.12% | 8,679 |
24-04-29 | 2.23 | -0.67% | 16,464 |
24-04-26 | 2.245 | +2.98% | 61,472 |
24-04-25 | 2.18 | -2.46% | 19,133 |
Real-time Euronext Paris, May 02, 2024 at 08:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.03% | 190M | |
+20.02% | 42.68B | |
-0.41% | 42.4B | |
+46.06% | 40.04B | |
-6.20% | 28.31B | |
+5.85% | 24.94B | |
-21.81% | 18.96B | |
+29.45% | 12.3B | |
-2.90% | 11.95B | |
-4.68% | 11.55B |
- Stock Market
- Equities
- IPH Stock